Search results
Results from the WOW.Com Content Network
Citalopram, sold under the brand name Celexa among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. [7] [10] It is used to treat major depressive disorder, obsessive compulsive disorder, panic disorder, and social phobia. [7] The antidepressant effects may take one to four weeks to occur. [7]
Citalopram (generic for Celexa) Sertraline (Zoloft) ... you can see if intimate performance improves on its own as your body gets used to the effects of your medication. ... This includes ...
Some medications share similar effects, while others work differently to target symptoms. ... Citalopram, sold under the name Celexa or Cipramil, is an SSRI designed to treat both mild and severe ...
The study found that the most used medications among the participant group were sertraline (Zoloft), citalopram (Celexa), and bupropion. Adherence to antidepressant use was between 28% and 41% at ...
[175] [176] Discontinuation effects appear to be less for fluoxetine, perhaps owing to its long half-life and the natural tapering effect associated with its slow clearance from the body. One strategy for minimizing SSRI discontinuation symptoms is to switch the patient to fluoxetine and then taper and discontinue the fluoxetine.
But citalopram can also be viewed as a constrained analogue of paroxetine. [6] Figure 7 Chemical structures of (R)- and (S)-enantiomers of citalopram. Citalopram has the second most selectivity for SERT, no effects on NE or DA re-uptake and nor does it have affinity to other neuroreceptors. [6]
Data from taking Celexa (citalopram), Lexapro (escitalopram), Prozac (fluoxetine), Paxil (paroxetine), Wellbutrin (bupropion), Cymbalta (duloxetine) and Effexor (venlafaxine) was compared to ...
The effects of antidepressants typically do not continue once the course of medication ends. This results in a high rate of relapse. In 2003, a meta-analysis found that 18% of people who had responded to an antidepressant relapsed while still taking it, compared to 41% whose antidepressant was switched for a placebo. [116]